LeMaitre Vascular financials
$82.89+0.67%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $249.6M | $219.9M | $193.5M | $161.7M | $154.4M | $129.4M | $117.2M | $105.6M | $100.9M | $89.2M |
| Gross profit | $178.5M | $150.9M | $127.0M | $104.9M | $101.4M | $84.6M | $79.9M | $73.9M | $70.7M | $62.9M |
| Gross margin | 71.5% | 68.6% | 65.7% | 64.9% | 65.7% | 65.4% | 68.1% | 70.0% | 70.1% | 70.6% |
| Operating income | $67.9M | $52.3M | $36.7M | $26.8M | $36.4M | $28.3M | $21.2M | $20.7M | $21.1M | $16.3M |
| Net income | $57.7M | $44.0M | $30.1M | $20.6M | $26.9M | $21.2M | $17.9M | $22.9M | $17.2M | $10.6M |
| Net margin | 23.1% | 20.0% | 15.6% | 12.8% | 17.4% | 16.4% | 15.3% | 21.7% | 17.0% | 11.9% |
| Diluted EPS | $2.52 | $1.93 | $1.34 | $0.93 | $1.25 | $1.04 | $0.88 | $1.13 | $0.86 | $0.55 |
| EBITDA | $78.3M | $61.9M | $46.7M | $39.4M | $47.5M | $36.7M | $26.6M | $25.1M | $25.2M | $19.9M |
| Operating cash flow | $81.3M | $44.1M | $36.8M | $25.4M | $35.1M | $34.8M | $14.0M | $19.5M | $22.8M | $16.9M |
| Free cash flow | $74.5M | $37.2M | $29.5M | $22.1M | $30.2M | $31.8M | $10.2M | $16.5M | $16.3M | $14.1M |
| Diluted shares | 22.9M | 22.8M | 22.4M | 22.2M | 21.5M | 20.5M | 20.3M | 20.2M | 20.0M | 19.2M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $28.2M | $25.6M | $24.3M | $19.1M | $13.9M | $26.8M |
| Short-term investments | $330.9M | $274.1M | $80.8M | $63.6M | $56.1M | $214.0K |
| Total debt | $168.6M | $167.8M | $0.00 | $0.00 | $0.00 | $38.8M |
| Total assets | $615.7M | $551.8M | $346.8M | $310.5M | $292.8M | $252.8M |
| Total liabilities | $222.2M | $214.5M | $48.9M | $42.3M | $38.7M | $80.2M |
| Shareholders' equity | $393.5M | $337.3M | $297.9M | $268.2M | $254.2M | $172.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology